NASDAQ : SBC
SBC Medical Group Holdings Incorporated — Key statistics
Industrials · Consulting Services · United States
Last price 5.69 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 585.20M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 546.12M |
| Enterprise Value | 409.73M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 102.85M |
| Shares Outstanding | 102.85M |
| Shares Change (YoY) | +1.41% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 82.37% |
| Owned by Institutions (%) | 4.42% |
| Float | 18.10M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 11.11 |
| Forward PE | 10.67 |
| PS Ratio | 3.12 |
| Forward PS | 2.75 |
| PB Ratio | 2.06 |
| P/TBV Ratio | 2.69 |
| P/FCF Ratio | 9.00 |
| P/OCF Ratio | 8.69 |
| PEG Ratio | 2.13 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 8.36 |
| EV / Sales | 2.34 |
| EV / EBITDA | 5.97 |
| EV / EBIT | 6.26 |
| EV / FCF | 6.75 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 3.31 |
| Quick Ratio | 3.19 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 0.65 |
| Debt / FCF | 0.79 |
| Interest Coverage | 187.88 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 18.91% |
| Return on Assets (ROA) | 11.33% |
| Return on Invested Capital (ROIC) | 29.05% |
| Return on Capital Employed (ROCE) | 19.93% |
| Weighted Average Cost of Capital (WACC) | 6.74% |
| Revenue Per Employee | $202,976 |
| Profits Per Employee | $56,809 |
| Employee Count | 863 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 21.05 |
Taxes
| Measure | Value |
|---|
| Income Tax | 25.31M |
| Effective Tax Rate | 33.79% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +62.88% |
| 50-Day Moving Average | 4.89 |
| 200-Day Moving Average | 3.91 |
| Relative Strength Index (RSI) | 52.45 |
| Average Volume (20 Days) | 187,207 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 750,813 |
| Short Previous Month | 813,900 |
| Short % of Shares Out | 0.73% |
| Short % of Float | 4.15% |
| Short Ratio (days to cover) | 3.46 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 175.17M |
| Gross Profit | 125.86M |
| Operating Income | 65.41M |
| Pretax Income | 74.92M |
| Net Income | 49.03M |
| EBITDA | 68.63M |
| EBIT | 65.41M |
| Earnings Per Share (EPS) | $0.48 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 184.62M |
| Total Debt | 48.23M |
| Net Cash | 136.39M |
| Net Cash Per Share | $1.33 |
| Equity (Book Value) | 279.92M |
| Book Value Per Share | 2.57 |
| Working Capital | 180.93M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 62.82M |
| Capital Expenditures | -2.12M |
| Depreciation & Amortization | 3.22M |
| Net Borrowing | 29.47M |
| Free Cash Flow | 60.70M |
| FCF Per Share | $0.59 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.85% |
| Operating Margin | 37.34% |
| Pretax Margin | 42.77% |
| Profit Margin | 27.99% |
| EBITDA Margin | 39.18% |
| EBIT Margin | 37.34% |
| FCF Margin | 34.65% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.41% |
| Shareholder Yield | -1.41% |
| Earnings Yield | 9.00% |
| FCF Yield | 11.12% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $8.75 |
| Price Target Difference | 64.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 9.35% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.33 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |